BIVDA Press Releases

22Oct

BIVDA comment on the Health and Social Care Committee’s report into Antimicrobial resistance

22nd October 2018

Today the Health and Social Care Committee has published its report on Antimicrobial resistance.

The report calls for visible and active Government leadership to tackle Antimicrobial resistance (AMR) and for AMR to be firmly established as a top five policy priority for the Government.

Doris-Ann Williams, BIVDA’s Chief Executive, commented: “Urgent action is required to halt AMR. While the widespread use of broad-spectrum antibiotics has helped to create multi-drug resistant strains of bacteria, greater adoption of IVDs would lead to a reduction in cases of unnecessary antibiotic prescribing by reducing time to appropriate treatment decision and allowing for a more targeted use of therapy against infection.” 

“We therefore welcome the Committee’s conclusion that encouraging the development of rapid diagnostic testing should be considered alongside the action to promote the development of new antimicrobials. We look forward to continuing to contribute a clear voice on the importance of in vitro diagnostics in tackling AMR and to working together with government and policymakers to build on the urgent issues raised in today’s report”. 

The report by the Health and Social Care Committee into Antimicrobial resistance can be found here.

For more information on the In Vitro Diagnostics (IVD) industry Antimicrobial Resistance (AMR) Declaration, click here

 

Related

Autumn Statement 2016: BIVDA’s Response

Commenting on the 2016 Autumn Statement, BIVDA’s Chief Executive Doris-Ann Williams MBE said: “...

Read More >

BIVDA Welcomes AAR Funding Announcement

Commenting on the Government’s announcement today (14 July 2017) regarding funding for the Accelera...

Read More >

BIVDA statement on the publication of the NHS Long Term Plan

Doris-Ann Williams, Chief Executive of BIVDA, comments on the publication of the NHS Long Term Plan ...

Read More >

BIVDA joins declaration by industry on combating antimicrobial resistance

BIVDA has joined more than 80 leading international pharmaceutical, generics, diagnostics and biotec...

Read More >

European Parliament endorses new Regulation on In Vitro Diagnostics

The European Parliament has endorsed the new Regulation on In Vitro Diagnostics (IVDR), a developmen...

Read More >

BIVDA Board elects Darren Stenlake as Chair

Darren Stenlake (Sysmex UK Ltd) has been elected as Chairman of the BIVDA Board

Read More >